Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B
Jay H. Lefkowitch(Columbia College), Roger Vaughan(Columbia University), Alexandra L. Gibas(Massachusetts General Hospital), Henry C. Bodenheimer(Donaldson (United States)), Eugene R. Schiff(University of Miami), Bharati Sanghvi, Jules L. Dienstag(Massachusetts Department of Public Health), Richard E. Sampliner(American College of Gastroenterology), Carlton Meschievitz, Ira M. Jacobson(Cornell University), David Feit(Hackensack University Medical Center), Robert P. Perrillo(Ochsner Medical Center), David H. Van Thiel(University of Pittsburgh), Luis A. Balart(Ochsner Medical Center), Carlo H. Tamburro(University of Louisville), John A. Payne(Digestive Care (United States)), Terryl J. Ortego(Ochsner Medical Center), Janice K. Albrecht, Christopher O'Brien(Hospital of the University of Pennsylvania), G. Davis(University of Florida), Karen L. Lindsay(University of California, Los Angeles)
Cited by 374
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
The Natural History of Community-Acquired Hepatitis C in the United States
|New England Journal of Medicine|1992|1.6k
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k